基础医学与临床 ›› 2012, Vol. 32 ›› Issue (5): 583-586.

• 短篇综述 • 上一篇    下一篇

喉癌相关miRNA的研究进展

吴一波,郭俊明,余 星,刘 洋,于雪林,赵晓彦   

  1. 宁波大学
  • 收稿日期:2011-08-14 修回日期:2011-11-14 出版日期:2012-05-05 发布日期:2012-04-16
  • 通讯作者: 郭俊明 E-mail:junmingguo@yahoo.com
  • 基金资助:
    浙江省新苗人才计划项目

Research advances of microRNAs related to laryngeal carcinoma

  • Received:2011-08-14 Revised:2011-11-14 Online:2012-05-05 Published:2012-04-16
  • Contact: Jun-Ming GUO E-mail:junmingguo@yahoo.com
  • Supported by:
    College Students' Science-Technology Innovation Program of Zhejiang Province

摘要: 喉癌是耳鼻咽喉头颈外科常见的肿瘤之一,其发病机制尚未完全明确。研究发现,微小RNA(microRNA,miRNA)在喉癌的发生过程中发挥着重要的作用。miRNA的表达异常(如miR-106b-25和miR-21等的上调,miR-375和let-7a等的下调)与喉癌的发生有关。在喉癌组织中异常表达的miRNA为喉癌的诊断提供了新标志物,而相关miRNA更是为喉癌治疗提供了潜在的靶点。

关键词: 喉癌, 微小RNA, 肿瘤标志物, 治疗靶点

Abstract: Laryngeal carcinoma is one of the most common cancers in otolaryngology-head and neck surgery. However, its pathogenesis is unclear. Studies have shown that microRNAs (miRNAs) play an important role in the carcinogenesis of laryngeal carcinoma. The abnormal expressions of miRNAs (such as upexpression of miR-106b-25 and miR-21 etc., downexpression of miR-375 and let-7a etc.) are related with the occurrence of laryngeal carcinoma. The abnormal expressed miRNAs in laryngeal carcinoma tissues can be used as tumor markers in the diagnosis of laryngeal carcinoma. Furthermore, some miRNAs may be used as targets for the treatment of laryngeal carcinoma.

Key words: laryngeal carcinoma, microRNA, tumor marker, treatment target

中图分类号: